Clinical Trials in San Francisco

Showing 7621-7640 of 12,991 trials

Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training

NCT01360216

The purpose of the study is to measure whether an education and training intervention for clinicians and contraceptive counselors on long-acting reversible contraception (LARC) will result in greater use of the methods among contraceptive patients.

Contraception Behavior

University of California, San Francisco1,500 participantsStarted May 2011

San Francisco, California, United States

TERMINATEDPhase 3< 1 mile

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

NCT02718417

This is a Phase 3, open-label, international, multi-center, efficacy, and safety study of avelumab in combination with and/or following platinum-based chemotherapy. Eligible patients must have previously untreated, histologically confirmed Stage III-IV epithelial ovarian (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) and be candidates for platinum-based chemotherapy. The primary purpose of the study is to demonstrate if avelumab given as single agent in the maintenance setting following frontline chemotherapy or in combination with carboplatin/paclitaxel is superior to platinum-based chemotherapy alone followed by observation in this population of newly diagnosed ovarian cancer patients.

Ovarian Cancer

Pfizer998 participantsStarted May 2016

Alabaster, Alabama, United States • Bessemer, Alabama, United States • Birmingham, Alabama, United States +316 more locations

Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Find Trials by Condition in San Francisco

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

Perioperative Virtual Reality for Pediatric Anesthesia

Reversing Therapy Resistance With Epigenetic-Immune Modification

Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)

Viral Triggers in Pediatric Lung Transplantation

The Effects of a Life Coaching Seminar on Gratitude and Psychological Well-Being

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine